Inflammation
Omega-3 fatty acids for CV risk reduction: The one that did not get away
BLOG: Cataract surgery: Drop free, on label and best results ever
By watching my three children playing together, I’ve learned that the importance of pain depends on whether you’re the one giving it or the one receiving it. Similarly, the size of the burden of using eye drops depends on whether you’re the one prescribing them or taking them. We physicians have grown accustomed to prescribing three eye drop medications to be taken for a month or longer after surgery, assuming that the average cataract patient — age 69 — will take them flawlessly. How wrong we are! Studies by Angela An and others have shown that more than 90% of patients taking eye drops fail. If we listen, our own patients tell us about their problems with compliance; in a 2018 study by MDbackline asking patients what was their biggest complaint about cataract surgery, 10% brought up the subject of eye drops as a consistently formidable task.
BLOG: Angiogenesis 2020: Noteworthy and notable presentations
The Bascom Palmer Angiogenesis meeting took place on Feb. 8, covering disease pathogenesis and emerging treatment options for various retinal conditions. The presentations highlighted how some of the newest imaging modalities are helping us understand the natural course of disease and new mechanisms of action being evaluated as alternatives to our current treatments. Below is just a mere highlight of many excellent presentations at the meeting.
Preliminary data show intracameral implant reduces IOP up to 9 months
VIDEO: Perform MMP-9 test before cataract surgery
Diabetes, obesity associated with cognitive decline in older adults
Sustained blood sugar elevations were linked to an increased risk for cognitive decline in older adults, according to results of a population-based study published in Journal of the American Geriatrics Society. Researchers also found that the hormone adiponectin was likely a risk factor for cognitive decline in older adults without abdominal obesity.
Association between arterial stiffness, depression mediated by metabolic syndrome, inflammation
Future cardiovascular risk among adult patients with depression may be identifiable early using combined data on metabolic syndrome and inflammation, according to results of a population-based cohort study published in JAMA Psychiatry. Researchers used this data to determine that one-third of the association of depression with elevated arterial stiffness index levels during midlife may be accounted for by combined inflammatory and metabolic syndrome processes.
Cardiology Today’s ‘top news’ of the past decade and a look ahead
Matossian, Berdahl debate postop inflammation management
‘Metabolic flexibility’ reduced during pregnancy for women with overweight or obesity
Lipid oxidation rate — an indicator of “metabolic flexibility” — may be greater among women with normal weight vs. women with overweight or obesity during pregnancy, according to findings published in Metabolism. In addition, insulin resistance and inflammation may be influenced by this flexibility.